---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-117981"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2025-12-03T23:59:59+00:00"
generated_at: "2026-05-16T15:01:41.555218+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Capricor provides HOPE-3 trial update via slide presentation, no new data disclosed

## Summary
- Filed Item 7.01 with slide presentation dated Dec 3, 2025 on HOPE-3 Phase 3 top-line results.
- Slide presentation contains no specific efficacy or safety numbers in the attached exhibit.
- Company held conference call; full slides available on investor website.
- No materially new financial or clinical information beyond prior top-line announcement.

## SEC filing metadata
- accession: 0001104659-25-117981
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2025-12-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000110465925117981/0001104659-25-117981-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000110465925117981/capr-20251203x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-117981
- JSON: https://secwatch.observer/filing/0001104659-25-117981.json
- Plain text: https://secwatch.observer/filing/0001104659-25-117981.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.